Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Appointed director
|
|
Sage Therapeutics, Inc. (SAGE)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2020 |
GN
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics (SAGE) Investors With 100K+ Losses to Contact Its Attorneys: Firm Investigating Potential Securities Fraud |
| 12/11/2019 |
GN
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. (SAGE) Investors With 100K+ Losses to Contact Its Attorneys, Securities Fraud Investigation Opened |
| 10/30/2019 |
GN
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Sage Therapeutics, Inc.- SAGE |
| 03/05/2019 |
GN
| Market Trends Toward New Normal in Macy's, Comerica, JetBlue Airways, Intersect ENT, Stanley Black & Decker, and Sage Therapeutics — Emerging Consolidated Expectations, Analyst Ratings |
| 02/08/2019 |
GN
| Factors of Influence in 2019, Key Indicators and Opportunity within New Relic, Clean Harbors, Sage Therapeutics, Accelerate Diagnostics, Fortinet, and Colfax — New Research Emphasizes Economic Growth |
| 11/29/2018 |
GN
| New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors — Factors of Influence, Major Initiatives and Sustained Production |
| 06/12/2018 |
GN
| Market Trends Toward New Normal in Cheniere Energy Partners, LP, UnitedHealth Group, Anthem, Sage Therapeutics, Harris, and A-Mark Precious Metals — Emerging Consolidated Expectations, Analyst Ratings |
| 05/08/2018 |
BW
| Sage Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference |
| 05/03/2018 |
BW
| Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness |
| 04/24/2018 |
BW
| Sage Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 3, 2018 |
| 02/22/2018 |
BW
| Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update |
| 02/20/2018 |
GN
| Research Report Identifies Advanced Disposal Services, Opus Bank, Anworth Mortgage Asset, Exelon, Newell Brands, and Sage Therapeutics with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement |
| 02/13/2018 |
BW
| Sage Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, February 22, 2018 |
| 12/07/2017 |
BW
| Sage Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference |
| 12/07/2017 |
BW
| Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder |
| 12/04/2017 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Exelon, Newell Brands, Sage Therapeutics, Advanced Disposal Services, Opus Bank, and Anworth Mortgage Asset — New Research Emphasizes Economic Growth |
| 11/02/2017 |
BW
| Sage Therapeutics Announces Third Quarter 2017 Financial Results and Provides Pipeline Update |
|
|